Download
s11764-020-00947-y.pdf 525,75KB
WeightNameValue
1000 Titel
  • Antidepressant prescriptions and associated factors in men with prostate cancer and their female partners
1000 Autor/in
  1. Hartung, Tim |
  2. Moustsen, Ida Rask |
  3. Larsen, Signe Benzon |
  4. Wreford Andersen, Elisabeth A. |
  5. Suppli, Nis P. |
  6. Johansen, Christoffer |
  7. Tjønneland, Anne |
  8. Friberg, Anne S. |
  9. Kjær, Susanne K. |
  10. Brasso, Klaus |
  11. Kessing, Lars V. |
  12. Mehnert, Anja |
  13. Dalton, Susanne Oksbjerg |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-10-13
1000 Erschienen in
1000 Quellenangabe
  • 15(4):536-545
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11764-020-00947-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272693/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose: To estimate the risk of first-time antidepressant prescriptions as a proxy for depression or anxiety and associated risk factors in patients with prostate cancer and their female partners. Methods: We followed all men (n = 25,126) and their female cohabiting partners (n = 8785) without a history of cancer or antidepressants from the Danish Diet, Cancer and Health cohort from 1997 to 2014 or 2010, respectively. We estimated the cumulative incidence of first-time antidepressant prescriptions in men with prostate cancer compared with cancer-free men and their respective female partners, using the Danish National Prescription Registry. Sociodemographic, lifestyle-related, and clinical risk factors were assessed using Cox regression models. Results: A total of 1828 men were diagnosed with prostate cancer of whom 15% received antidepressants. The unadjusted hazard ratio of antidepressant prescription was 2.18 (95%CI, 1.92, 2.48) for men with prostate cancer and 1.27 (95%CI, 0.87, 1.85) for their partners, compared with cancer-free men and their partners, respectively. After adjusting for sociodemographic, lifestyle-related, and comorbidity factors, this risk was 2-fold to 4-fold increased among patients, but not significantly increased among partners. Significant risk factors among patients were curative and palliative treatment (vs. active surveillance and watchful waiting), nonlocalized disease, and short education. Conclusions: Men with prostate cancer have a higher risk of receiving antidepressant medication than cancer-free men. Clinical characteristics can help clinicians in identifying patients at a high risk of depression or anxiety. Implications for Cancer Survivors: Men with prostate cancer who experience symptoms of depression or anxiety should seek professional help early on. Patient education could aid in raising awareness and reducing the stigma associated with mental disorders.
1000 Sacherschließung
lokal Life style
lokal Humans [MeSH]
lokal Prostatic Neoplasms/epidemiology [MeSH]
lokal Prostatic Neoplasms/drug therapy [MeSH]
lokal Diet
lokal Anxiety disorders
lokal Cohort Studies [MeSH]
lokal Anxiety [MeSH]
lokal Article
lokal Depression
lokal Male [MeSH]
lokal Antidepressant agents
lokal Antidepressive Agents/therapeutic use [MeSH]
lokal Prescriptions [MeSH]
lokal Prostatic neoplasms
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-5929-4643|https://frl.publisso.de/adhoc/uri/TW91c3RzZW4sIElkYSBSYXNr|https://frl.publisso.de/adhoc/uri/TGFyc2VuLCBTaWduZSBCZW56b24=|https://frl.publisso.de/adhoc/uri/V3JlZm9yZCBBbmRlcnNlbiwgRWxpc2FiZXRoIEEu|https://frl.publisso.de/adhoc/uri/U3VwcGxpLCBOaXMgUC4=|https://frl.publisso.de/adhoc/uri/Sm9oYW5zZW4sIENocmlzdG9mZmVy|https://frl.publisso.de/adhoc/uri/VGrDuG5uZWxhbmQsIEFubmU=|https://frl.publisso.de/adhoc/uri/RnJpYmVyZywgQW5uZSBTLg==|https://frl.publisso.de/adhoc/uri/S2rDpnIsIFN1c2FubmUgSy4=|https://frl.publisso.de/adhoc/uri/QnJhc3NvLCBLbGF1cw==|https://frl.publisso.de/adhoc/uri/S2Vzc2luZywgTGFycyBWLg==|https://frl.publisso.de/adhoc/uri/TWVobmVydCwgQW5qYQ==|https://frl.publisso.de/adhoc/uri/RGFsdG9uLCBTdXNhbm5lIE9rc2JqZXJn
1000 Hinweis
  • DeepGreen-ID: 2d54b39d182c4189be4526c95a19001e ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6471212.rdf
1000 Erstellt am 2023-11-18T11:41:38.489+0100
1000 Erstellt von 322
1000 beschreibt frl:6471212
1000 Zuletzt bearbeitet Fri Dec 01 13:54:55 CET 2023
1000 Objekt bearb. Fri Dec 01 13:54:55 CET 2023
1000 Vgl. frl:6471212
1000 Oai Id
  1. oai:frl.publisso.de:frl:6471212 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source